Cara Therapeutics | CARA - Market Capitalization


Cara Therapeutics reported $112.6M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Alterity Therapeutics Limited AUD 47M 9M Jul/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cassava Sciences USD 52M 30M Jul/2026
Chugai Pharma JPY 14.46T 617.89B Mar/2026
Cipla INR 988.89B 231.9B Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 573.66M 46.63M Jul/2026
CSL USD 55.89B 20.42B Dec/2025
Halozyme Therapeutics USD 7.66B 257M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Pacira USD 915M 149M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
RedHill Biopharma USD 1000K 4M Jul/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024